An Evaluation of the Initiation and Use of Sacubitril/Valsartan in an Inpatient Heart Failure Population: A Retrospective Medication Use Evaluation
Guardado en:
Autores principales: | Tara Snyder, Krissy-Ann Thornby, Amy Henneman, Robert Thornby |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
California Pharmacists Association
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c0713ef4a464a198358a531163db999 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Renal protective effect of sacubitril/valsartan in patients with heart failure
por: Hui-Ling Hsieh, et al.
Publicado: (2021) -
Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
por: Cuthbert JJ, et al.
Publicado: (2020) -
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
por: Mauro Gori, et al.
Publicado: (2021) -
Sacubitril/valsartan in real-life clinical practice
por: Yüksel Çavuşoğlu
Publicado: (2021) -
Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red
por: Kateryna Peleshok, et al.
Publicado: (2021)